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 Volatile anesthetics would exert their effects by acting at 
specific target proteins in the central nervous system. 
Neuronal membrane hyperpolarization brought about by 
increased potassium channel conductance is hypothesized to 
contribute to a mechanism of volatile anesthetic action. The 
purpose of this study was to determine whether the activation 
of ATP-sensitive potassium (KATP) channels might play a 
potential role in the mechanism of anesthetic action. Four-
teen dogs were anesthetized with halothane or isoflurane. 
Following determination of the control minimum alveolar 
anesthetic concentration (MAC) of either anesthetic by a 
tail-clamp technique, KRN2391, a novel KATP channel opener, 
was infused intravenously at a dose of 3µg-kg-1.min-1 over 30 
min and the MAC was determined again. The plasma concen-
tration of KRN2391 was measured in all dogs. In additional 
3 dogs the time courses of KRN2391 concentration in plasma 
and cerebrospinal fluid (CSF) were determined. The MAC 
for halothane was significantly reduced from 0.86±0.15% to 
0.63±0.12% (P<0.01) by KRN2391 at a plasma level of 77 ng/ 
ml. In contrast the MAC for isoflurane was not altered by 
this compound. The CSF concentration of KRN2391 increased 
gradually during intravenous administration. The results 
suggest that activation of KATP channels would be involved in 
the mechanism of anesthetic action of halothane, whereas 
KATP channels would not play a role in isoflurane anesthesia.
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Introduction 
 Volatile anesthetics would exert their effects by acting 
at specific target proteins in the central nervous system 
(CNS )1'4) . A large body of work is in favor of direct 
interactions between volatile anesthetics and channel 
proteins'-") The increase in potassium conductance via 
potassium channels bringing about membrane hyper-
polarization of central neurons is thought to contribute to 
the anesthetic production","). Recently, several lines of 
evidence suggest that ATP-sensitive potassium channels 
(KATP channels) are widely distributed in CNS13) and play an 
important role in the modulation of CNS neurotransmitter 
release14.15> Moreover, a few studies have demonstrated
that the central administration of KATP channel openers 
produced antinociception or potentiated morphine-induced 
antinociceptive effect, and that KATP channel blockers 
antagonized morphine-induced antinociceptionl8-18>. These 
investigations raise a question whether the activation of 
KATP channels may play a substantial role in the mecha-
nism of general anesthesia. 
 Zucker1) reported that minimum alveolar concentration 
(MAC) for isoflurane in rats was unaffected by intra-
thecal administration of two agonists of KATP channels, 
cromkalim and pinacidil, concluding that activation of 
KATP channels was unlikely to be a fundamental mechanism 
of anesthesia. On the other hand, Maclver and Kendig4) 
compared the effects of halothane, isoflurane and 
enflurane on the resting membrane potential and conduc-
tance of rat hippocampal CAl neurons in vitro. They 
showed that anesthetic effects on resting membrane 
potential were voltage-dependent and agent-specific, 
suggesting that each volatile anesthetic might involve 
distinct ion channels. The present study was designed to 
clarify whether activation of KATP channels might play a 
potential role in the mechanism of anesthetic action of 
halothane or isoflurane. We measured MAC of halothane 
and isoflurane in dogs in the absence or presence of a novel 
potassium channel opener, KRN2391 [N-cyano-N'-(2-
nitroxyethyl)-3-pyridine-carboximidamide monomethane-
sulfonate] via intravenous administration. KRN2391 is a 
novel vasodilator, which shows a similar magnitude in 
inducing 86Rb efflux via KATP channels to that produced by 
cromakalim or by pinacidil, and has the property of 
crossing the blood brain barrier.',")
Methods 
 All experimental procedures and protocols described in 
this study were approved by the Animal Care Committee 
of Nagasaki University School of Medicine. General 
anesthesia was induced by one of two volatile anesthetics, 
halothane or isoflurane, in 100% oxygen via mask in 14 
healthy mongrel dogs of either sex weighing 12-15 kg. 
Tracheal intubation was accomplished with a cuffed
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endotracheal tube without the use of muscle relaxants. 
Mechanical ventilation was begun with a ventilator. 
End-tidal CO2 concentration was measured continuously by 
an infrared gas analyzer (Ultima, USA) and maintained at 
levels of 35-40 mmHg by adjusting the respiratory rate. 
Catheters were inserted into the right femoral artery and 
vein for arterial blood sampling and pressure monitoring 
and for intravenous fluid and drug administration. A 
heating lamp and an electrical blanket were used to 
maintain esophageal temperature at 37.0-38.51C. Lead II 
of ECG was monitored continuously. Both halothane and 
isoflurane concentrations were measured by means of an 
infrared gas analyzer calibrated automatically for each 
study according to the manufacturer's specifications. 
 The MAC of halothane or isoflurane necessary to 
prevent purposeful movement in response to tail clamping 
was determined according to the method of Eger et al'). 
Briefly, a 10-in hemostat was applied to the dog's tail 4-in 
from the base to the full ratchet continuously for 60 sec or 
until purposeful movement in response to the tail-clamp 
stimulus. A positive was defined as gross movement of the 
head or extremities and did not include coughing, chewing, 
swallowing, or increased respiratory effort. The end-tidal 
halothane or isoflurane concentration was adjusted either 
up or down stepwise by approximately 0.05-0.10% with an 
equilibration period of at least 15 min before each tail 
clamping. MAC was calculated as the halothane or 
isoflurane concentration midway between that which 
allowed and that which prevented movement. A first 
baseline halothane or isoflurane MAC was determined 
after 1 h of anesthetic administration. A second halothane 
or isoflurane MAC was determined during KRN2391 
(Kirin Brewery Co., Ltd., Gunma, Japan) administration. 
Following determination of the baseline MAC, the animal 
received intravenous KRN2391 dissolved in saline at a dose 
of 3,u g . kg`' . min-'. The KRN2391 was infused over 30 
min to achieve a pharmacologic effect. When halothane or 
isoflurane MAC was determined, a blood sample was 
drawn to determine the plasma concentration of KRN2391. 
 A separate group of three dogs was used to determine 
the time course of plasma and cerebrospinal fluid (CSF)
concentrations of KRN2391 during continuous infusion. 
The animal was anesthetized with halothane by the same 
manner as described above except for a fixed end-tidal 
concentration of 1%, and KRN2391 was administered 
intravenously at a dose of 3,u g • kg-' • min-'. With the 
animal in the lateral position, the cranio-cervical area was 
shaved, and a 20-G spinal needle was inserted 
percutaneously into the subarachnoid space at the atlanta-
occipital interspace. As clear CSF without blood mixing 
was identified, the infusion of KRN2391 was started, and 
samples from the two compartments, blood and CSF, were 
collected at 0, 15, 30 and 45 min after KRN2391. 
 Blood samples were centrifuged to separate plasma. The 
plasma and CSF samples were frozen and stored at - 70 
°C until assay . The plasma and CSF KRN2391 concentra-
tions were performed using high-performance liquid 
chromatography (HPLC). The results were expressed as 
mean±SD and analyzed statistically by the two-tailed t 
test for paired data. P <0.05 was considered statistically 
significant.
Results 
 As shown in Fig. 1, the baseline MAC for halothane was 
0.86±0.15%. KRN2391 reduced halothane MAC by 27% to 
0.63±0.12% (P<0.01). In contrast, as shown in Fig. 2, the 
MAC for isoflurane was not significantly changed by 
KRN2391, i.e., 1.24±0.21% and 1.25±0.21% before and 
after KRN2391, respectively. Table 1. shows the plasma 
concentration of KRN2391, hemodynamics and acid base 
balance. The mean plasma KRN2391 level at the time when 
the halothane MAC was determined was 77.6 ng/ml, and 
was similar to that of isof lurane group (78.4 ng/ml). The 
mean arterial pressure (MAP) significantly decreased by 
KRN2391 infusion during either anesthetic. However, there 
was no significant difference in the MAP between 
halothane and isoflurane anesthetized dogs, and there was 
no severe reduction in the MAP throughout the time course 
in either group (>70 mmHg) . The acid base status and the 
respiratory condition were maintained in the normal range
Table 1. Effects of KRN2391 on hemodynamics and acid base balance during halothane and isoflurane anesthesia
 Anesthetics Time KRN2391$ Mean Arterial Pressure § Arterial Blood Gases ¶                                     mmHg mmHg 
                  min ng/ml Pre- Post- pH Pot Pco2 
 H (not ha
)ne 80±21 77.±28 101±14 78±12* 7.41±0.03 458±69 36±2 
  Isoflurane 83±11 78±37 109±18 82±10* 7.39±0.04 425±91 37±1    (
n=7) 
Date are means±SD § Mean arterial blood pressure before and after 
$ Elapsed time between the two MAC determinations. KRN2391 infusion. 
$ Plasma KRN2391 concentration at post-KRN2391 MAC. $ Arterial blood gases at post-KRN2391 MAC. 
* P<0 .01 compared with MAP before KRN2391.
Fig. 1. Effects of KRN2391 on the MAC for halothane and 
isoflurane (mean±SD ; n = 7 for each point). KRN2391 was 
infused at 3,u g • kg-'- min-', and MAC was determined by the 
tail-clamp technique before (pre) and after (post) infusion of 
KRN2391 in dogs. 
* P<0.01 vs pre-KRN2391.
in either group, and there was no significant difference in 
pH, P02 or PCO2 between the groups. The mean period of 
time between the pre- and post- MAC determination was 
80.7 min in halothane and 83.6 min in isoflurane group, and 
there was no significant difference between the groups. 
 Fig. 2 shows the time course of plasma and CSF concen-
trations of KRN2391 infused at a dose of 3,u g • kg-' 
min-1. The plasma KRN2391 reached near maximum level 
within 15 min, although the level increased gradually 
thereafter. KRN2391 was sufficiently detected in the CSF 
at 15-min infusion, and the level increased as time went by.
Discussion 
 
. The present findings of a decrease in MAC with intrave-
nous administration of a potassium channel opener, 
KRN2391, for halothane but not for isoflurane in dogs 
suggest that activation of KATP channels would be involved 
in halothane-induced general anesthesia, whereas KATP 
channels would not play a role in the anesthetic action of 
isoflurane. 
 KATP channels were originally described in cardiac 
muscle'), but have now been well characterized in a variety 
of peripheral tissues. Recently, these channels have also 
been investigated in the CNS. KATP channels are present in 
a wide variety of neurons in CNS, including the substantia 
nigra13", hippocampus1" , globus pallidus'3", motor neo-
cortex' , and spinal dorsal horn'), and appear to be in-
volved in the regulation of neuronal excitability). 
 It was demonstrated that opioid27" and adenosine'" 
produce anesthetic-sparing effects through both u - or 8 -
Fig. 2. Time course of the concentration of KRN2391 in the 
plasma and cerebrospinal fluid (CSF) (mean±SD; n = 3 for 
each point). KRN2391 was infused at 3,u g • kg-'- min-' starting 
at time 0.
opioid receptors and A,-adenosine receptors, respectively. 
The molecular mechanisms involved in the analgesic state 
are believed that stimulation of p - or 8-opioid receptors'" 
and A,-adenosine receptors' open potassium channels 
resulting in membrane hyperpolarization in several areas 
of the CNS. Recently, some studies have indicated that 
KATP channels are coupled to several central neuronal 
pathways, and regulate some neurotransmitter releases 
and transmitter- mediated responses. The analgesic effects 
caused by activating opioidergic pathways have been 
demonstrated to involve the opening of KATF channels. 
Ocana et all'). observed that the administration of croma-
kalim dose-dependently potentiated the antinociceptive 
action of morphine in tail-flick test in mice, and that 
KATP channel antagonists abolished the antinociception. 
Likewise, recent evidence has also demonstrated a link 
between adenosine receptors and KATP channels in myo-
cytes30' and brain". Li and Henry' showed that neuronal 
membrane hyperpolarization produced by adenosine via 
A,-adenosine receptors was depressed by glibenclamide in 
vitro. The antinociception induced by (-)-N6-(2-phenyli-
sopropyl) -adenosine, an adenosine A, receptor agonist, 
was shown either to be potentiated by cromakalim or to be 
antagonized by KAY blocker, gliquidone31'. These studies 
together with our results suggest that the action of 
isoflurane is unlikely related to an action on KATP channels 
in the CNS. In contrast, the activation of KATP channels 
would be involved in the anesthetic action of halothane. 
 Maclver and Kendig4' compared the effects of halothane 
and isoflurane on resting membrane potential and conduc-
tance of hippocampal CAI neurons in vitro. At the equi-
anesthetic levels, halothane increased membrane con-
ductance and produced hyperpolarization, whereas isoflur-
ane decreased conductance and did not show significant 
effect on the membrane potential. Their results show that 
even structurally similar agents do not exert common 
hyperpolarizing effects on resting membrane potential or 
common changes in conductance. Our results are consistent 
with their studies supporting the view that different 
anesthetic agent might produce a common endpoint by 
multiple mechanisms via own selective ion channels. In the 
present study, KRN2391 was detected in the CSF, although 
there was a relatively large gradient in the concentration 
between plasma and CSF. This gradient might explain the 
relatively small magnitude of the reduction of halothane 
MAC by intravenous KRN2391. 
 General anesthetics would exert their effects by acting 
directly on specific target proteins in the CNS, in which a 
class of potassium channels seems to be particularly 
sensitive to volatile anesthetics. Nicoll and Madison"' 
showed that halothane directly hyperpolarizes both frog 
motoneurons and rat hippocampal neurons at concentra-
tions in the clinical range, possibly by an increase in 
potassium conductance. Reports of the hyperpolarizing 
actions of anesthetics in mammalian neurons"), and the 
finding that low concentrations of anesthetics hyper-
polarize and inhibit spontaneous activity of neurons in the 
pond snail Lymnaea stagnalis') suggest that potassium 
channels in the CNS are presumably the target sites 
underlying the molecular basis of volatile anesthetics. 
However, Stanford and Lacey14) indicated that the firing 
rate of single substantia nigra pars reticulata neurons 
recorded extracellularly in brain slices was unaffected by 
lemakalim in normal physiological conditions. Thus, it is 
unlikely that direct neuronal hyperpolarization by KATP 
channel openers may contribute to the mechanism involved 
in the altering effects of halothane. It is considered 
possible that halothane would activate KAY channels and 
KRN2391 potentiates the halothane effect, whereas 
isoflurane would not affect KATP channels. 
 It is unlikely that halothane MAC reduction may be due 
to the hypotension caused by KRN2391, because isoflurane 
MAC was not changed by KRN2391 in spite of a similar 
decrease in blood pressure. It has been suggested that 
moderate systemic hypotension per se does not alter MAC 
except the mean blood pressure below 50 mmHg3 ). In the 
present study, the arterial blood pressure showed a moder-
ate reduction but was kept over 70 mmHg in both groups. 
Therefore, the moderate hypotension induced by KRN2391 
is not a tenable explanation for the alteration of MAC for 
halothane. 
 There was a considerable evidence to show that the 
vasorelaxation caused by KRN2391 was antagonized not 
only by glibenclamide but also by TEA and 4-AP21', sug-
gesting that KRN2391 agonizes both KATP channels and 
voltage-gated potassium channels. Thus the action of 
KRN2391 does not appear to be confined exclusively to
KATP channels. Either KAY channels or voltage-gated 
potassium channels or both may be involved in the mecha-
nism of the KRN2391-induced halothane MAC reduction. 
However, Franks and Lieb') have summarized from avail-
able evidence that voltage-gated potassium channels are 
very resistant to clinical concentrations of general anes-
thetics, and appear unlikely to play a potential role in the 
production of anesthetic state. 
 In conclusion, as a proof of the hypothesis that different 
anesthetic agents might produce a common endpoint by 
differential mechanisms via own specific targets, the 
present study demonstrates that activation of KATP chan-
nels would be involved in the mechanism of anesthetic 
action of halothane, whereas KATP channels would not play 
a role in isoflurane anesthesia.
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